CORONA Remedies Limited

₹2,534As of Sun 8 Nov 2026, 12:00 UTC
NSE:CORONAHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield 0.39%
ROE 28.27%
Drug Manufacturers (General)
Beta (5Y) —
PE TTM 74.87
TSR TTM —
Mkt cap ₹155.0B
ROIC 25.70%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹3,228
27.37%
29.81%
Hold 2|0|9|12|10
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
30.31
32.30
33.14
32.93
19.54%
17.73%
13.00%
15.37%
Revenue₹B
9.034
8.940
8.852
9.213
9.09%
6.26%
6.26%
4.46%
Peers (US$1.590B)
Cap (US$)
PE
2.925B
85.29x
1.879B
20.53x
1.545B
—
Capital
TTM
5Y
10Y
Leveragex
0.515
(0.120)
(0.120)
EBIT/Intx
1.362
0.047
0.053
Own earn%
(40.08)
(79.63)
(76.74)
Sh yield%
47.51
25.71
20.33
Owners
Insiders/Inst%
12.46
23.64
Short interest%
3.95
SBC / revenue%
3.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
5–10
$1 testx
−0.2
Incr. ROIC%
2